{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:09:30Z","timestamp":1790388570723,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","award":["10002"],"award-info":[{"award-number":["10002"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/jid.2014.356","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T14:00:48Z","timestamp":1409061648000},"page":"247-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["CD158k Is a Reliable Marker for Diagnosis of S\u00e9zary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells"],"prefix":"10.1016","volume":"135","author":[{"given":"H\u00e9l\u00e8ne","family":"Moins-Teisserenc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Daubord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Douay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Marie-Cardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ram-Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guitta","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheira","family":"Beldjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Homyrda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.356_bb0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1051\/medsci\/2006222192","article-title":"Epidermotropic T cell lymphomas as models for tumor progression","volume":"22","author":"Bagot","year":"2006","journal-title":"Med Sci (Paris)"},{"key":"10.1038\/jid.2014.356_bb0015","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cyto.b.20395","article-title":"CD158k\/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry","volume":"74","author":"Bahler","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1038\/jid.2014.356_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.356_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.0022-202X.2005.23914.x","article-title":"Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients","volume":"125","author":"Bouaziz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.356_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.2009.09364.x","article-title":"Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sezary syndrome","volume":"162","author":"Bouaziz","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.356_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0045","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/blood-2010-05-287664","article-title":"High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma","volume":"117","author":"Clark","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0050","doi-asserted-by":"crossref","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2014.356_bb0055","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0060","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","article-title":"Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma","volume":"96","author":"Delfau-Larue","year":"2000","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ajcp\/114.3.467","article-title":"Diminished CD3 expression is useful for detecting and enumerating Sezary cells","volume":"114","author":"Edelman","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2014.356_bb0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.356_bb0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000096191","article-title":"Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sezary syndrome","volume":"213","author":"Fierro","year":"2006","journal-title":"Dermatology"},{"key":"10.1038\/jid.2014.356_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000112928","article-title":"Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma","volume":"216","author":"Fierro","year":"2008","journal-title":"Dermatology"},{"key":"10.1038\/jid.2014.356_bb0085","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.4049\/jimmunol.175.10.6489","article-title":"Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27","volume":"175","author":"Fritsch","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.356_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0190-9622(96)90605-2","article-title":"Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses","volume":"35","author":"Harmon","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.356_bb0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2133.2008.08739.x","article-title":"The diagnosis of Sezary syndrome on peripheral blood by flow cytometry requires the use of multiple markers","volume":"159","author":"Klemke","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.356_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb00943.x","article-title":"Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes","volume":"155","author":"Moretta","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1038\/jid.2014.356_bb0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/25E9Y7RRAY84HTAT","article-title":"A comparison of morphologic features, flow cytometry, TCR-V\u03b2eta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome","volume":"125","author":"Morice","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2014.356_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.356_bb0115","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2014.356_bb0120","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2005-10-4239","article-title":"Significance of circulating T-cell clones in Sezary syndrome","volume":"107","author":"Ortonne","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.jid.5701013","article-title":"CD158K\/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sezary syndrome","volume":"128","author":"Ortonne","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.356_bb0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nri1416","article-title":"Seventeen-colour flow cytometry: unravelling the immune system","volume":"4","author":"Perfetto","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2014.356_bb0135","first-page":"1053","article-title":"A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites","volume":"136","author":"Picker","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2014.356_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Poszepczynska-Guigne","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.356_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20061681","article-title":"Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells","volume":"204","author":"Riou","year":"2007","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2014.356_bb0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Ann Rev Immunol"},{"key":"10.1038\/jid.2014.356_bb0155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1038\/jid.2014.356_bb0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1365-2141.2002.03726.x","article-title":"The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas","volume":"118","author":"Schwab","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1038\/jid.2014.356_bb0165","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1371\/journal.pmed.0040253","article-title":"Expansion of regulatory T cells in patients with Langerhans cell histiocytosis","volume":"4","author":"Senechal","year":"2007","journal-title":"PLoS Med"},{"key":"10.1038\/jid.2014.356_bb0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2014.356_bb0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1309\/AJCP7QHH5XASTJPL","article-title":"Immunophenotypic stability of Sezary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy","volume":"137","author":"Vaughan","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1038\/jid.2014.356_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0303-6987.2006.00541.x","article-title":"On the diagnosis of erythrodermic cutaneous T-cell lymphoma","volume":"33","author":"Vonderheid","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1038\/jid.2014.356_bb0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.1251","article-title":"Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes","volume":"199","author":"Wechsler","year":"2003","journal-title":"J Pathol"},{"key":"10.1038\/jid.2014.356_bb0190","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0195","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"10.1038\/jid.2014.356_bb0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1067\/mjd.2001.116345","article-title":"Complete molecular remission during biologic response modifier therapy for Sezary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity","volume":"45","author":"Yoo","year":"2001","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1537041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1537041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:46:01Z","timestamp":1743975961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1537041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022202X1537041X"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.356","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD158k Is a Reliable Marker for Diagnosis of S\u00e9zary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}